Patents by Inventor Meng F. Ho

Meng F. Ho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Blood-based assay for dysferlinopathies
    Patent number: 7172858
    Abstract: It has been discovered that dysferlin is expressed in blood and that individuals who lack dysferlin in muscle also lack it in CD14(+) cells. Based on these discoveries, blood-based tests for dysferlin expression and uses of such tests are described.
    Type: Grant
    Filed: November 27, 2002
    Date of Patent: February 6, 2007
    Assignees: The General Hospital Corporation, Hospital Sta Creu I Sant Pau
    Inventors: Robert H. Brown, Jr., Meng F. Ho, Isabel Illa, Eduardo Gallardo
  • Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy
    Patent number: 6673909
    Abstract: A novel gene and the protein encoded therein, i.e., dysferlin, are disclosed. This gene and its expression products are associated with muscular dystrophy, e.g., Miyoshi myopathy and limb girdle musclular dystrophy 2B.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: January 6, 2004
    Assignee: The General Hospital Corporation
    Inventors: Robert H. Brown, Jr., Jing Liu, Masashi Aoki, Meng F. Ho, Chie Matsuda-Asada
  • Blood-based assay for dysferlinopathies
    Publication number: 20030165937
    Abstract: It has been discovered that dysferlin is expressed in blood and that individuals who lack dysferlin in muscle also lack it in CD14(+) cells. Based on these discoveries, blood-based tests for dysferlin expression and uses of such tests are described.
    Type: Application
    Filed: November 27, 2002
    Publication date: September 4, 2003
    Inventors: Robert H. Brown, Meng F. Ho, Isabel Illa, Eduardo Gallardo